W. H. Aellig

414 total citations
30 papers, 284 citations indexed

About

W. H. Aellig is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, W. H. Aellig has authored 30 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pharmacology and 7 papers in Anesthesiology and Pain Medicine. Recurrent topics in W. H. Aellig's work include Pharmacology and Obesity Treatment (6 papers), Anesthesia and Sedative Agents (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). W. H. Aellig is often cited by papers focused on Pharmacology and Obesity Treatment (6 papers), Anesthesia and Sedative Agents (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). W. H. Aellig collaborates with scholars based in Japan, Switzerland and United Kingdom. W. H. Aellig's co-authors include J. Rosenthaler, Laurence Després, B. Berde, P. Wyss, B. N. C. Prichard, K. Saameli, B. Scales and H. Narjes and has published in prestigious journals such as British Journal of Pharmacology, American Heart Journal and Clinical Pharmacology & Therapeutics.

In The Last Decade

W. H. Aellig

27 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. H. Aellig Japan	11	89	66	63	57	42	30	284
A J Boakes United Kingdom	10	122 1.4×	87 1.3×	79 1.3×	55 1.0×	113 2.7×	16	416
E. A. M. Neill United Kingdom	7	53 0.6×	88 1.3×	207 3.3×	23 0.4×	41 1.0×	8	360
JW Dundee United Kingdom	8	32 0.4×	77 1.2×	144 2.3×	84 1.5×	63 1.5×	12	372
E. Rügheimer Germany	9	35 0.4×	59 0.9×	103 1.6×	22 0.4×	21 0.5×	32	329
G. W. BLACK United Kingdom	10	69 0.8×	67 1.0×	190 3.0×	25 0.4×	45 1.1×	44	364
E. Couderc France	9	171 1.9×	205 3.1×	180 2.9×	30 0.5×	33 0.8×	21	478
G. R. Murray United Kingdom	9	23 0.3×	157 2.4×	149 2.4×	48 0.8×	75 1.8×	22	440
M.B. Meyer United States	10	180 2.0×	121 1.8×	37 0.6×	21 0.4×	57 1.4×	13	439
K. W. Harper United Kingdom	8	49 0.6×	84 1.3×	313 5.0×	122 2.1×	48 1.1×	10	521
N. J. Halliday United States	9	66 0.7×	112 1.7×	275 4.4×	107 1.9×	43 1.0×	17	524

Countries citing papers authored by W. H. Aellig

Since Specialization

Citations

This map shows the geographic impact of W. H. Aellig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. H. Aellig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. H. Aellig more than expected).

Fields of papers citing papers by W. H. Aellig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. H. Aellig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. H. Aellig. The network helps show where W. H. Aellig may publish in the future.

Co-authorship network of co-authors of W. H. Aellig

This figure shows the co-authorship network connecting the top 25 collaborators of W. H. Aellig. A scholar is included among the top collaborators of W. H. Aellig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. H. Aellig. W. H. Aellig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aellig, W. H.. (1998). Adverse Reactions to Antihypertensive Therapy. Cardiovascular Drugs and Therapy. 12(2). 189–196. 10 indexed citations

Wyss, P., et al.. (1991). Pharmacokinetic investigation of oral and IV dihydroergotamine in healthy subjects. European Journal of Clinical Pharmacology. 41(6). 597–602. 19 indexed citations

Aellig, W. H.. (1990). Superficial hand and foot veins show no difference in sensitivity to constrictor agents. Clinical Pharmacology & Therapeutics. 48(1). 96–101. 8 indexed citations

Aellig, W. H.. (1986). Constrictor effects of dihydroergotamine and noradrenaline on superficial hand and foot veins. British Journal of Clinical Pharmacology. 21(5). 559. 1 indexed citations

Aellig, W. H.. (1986). Direct effects of vasoactive substances on superficial human veins in vivo.. PubMed. 4(2). 235–42. 5 indexed citations

Aellig, W. H., et al.. (1982). Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tablets. European Journal of Clinical Pharmacology. 21(6). 451–455. 5 indexed citations

Aellig, W. H.. (1982). Clinical pharmacology of pindolol. American Heart Journal. 104(2). 346–356. 25 indexed citations

Aellig, W. H., et al.. (1981). A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet. European Journal of Clinical Pharmacology. 20(3). 179–183. 9 indexed citations

Aellig, W. H.. (1978). Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers. European Journal of Clinical Pharmacology. 14(3). 167–169. 10 indexed citations

10.

Aellig, W. H.. (1978). Activity and duration of action of pindolol and alprenolol compared in healthy volunteers. European Journal of Clinical Pharmacology. 14(5). 305–308. 5 indexed citations

11.

Aellig, W. H.. (1977). EXPERIMENTS WITH PINDOLOL (VISKEN) IN HEALTHY VOLUNTEERS. The Medical Journal of Australia. 2(SP2). 8–11. 4 indexed citations

12.

Aellig, W. H.. (1977). Investigations with beta-adrenoceptor blocking drugs in healthy Volunteers. Current Medical Research and Opinion. 4(sup5). 24–30. 2 indexed citations

13.

Aellig, W. H.. (1976). Venentonisierende Wirkung von Ergotalkaloiden, untersucht an oberflächlichen Handvenen <i>in sit</i><i>u</i>. Cardiology. 61(1). 302–308. 1 indexed citations

14.

Aellig, W. H.. (1974). Venoconstrictor effect of dihydroergotamine in superficial hand veins. European Journal of Clinical Pharmacology. 7(2). 137–139. 23 indexed citations

15.

Aellig, W. H. & K. Saameli. (1973). Prolonged action of pindolol.. BMJ. 2(5862). 365.3–365. 8 indexed citations

16.

Aellig, W. H., et al.. (1970). CARDIAC EFFECTS OF ADRENALINE AND FELYPRESSIN AS VASOCONSTRICTORS IN LOCAL ANAESTHESIA FOR ORAL SURGERY UNDER DIAZEPAM SEDATION. British Journal of Anaesthesia. 42(2). 174–176. 20 indexed citations

17.

Aellig, W. H. & B. N. C. Prichard. (1970). The effect of graded doses of practolol on the tachycardia induced by isoprenaline, Valsalva's manoeuvre and exercise.. PubMed. 39(1). 193P–194P. 2 indexed citations

18.

Aellig, W. H., et al.. (1970). Intravenous diazepam in minor oral surgery. Further studies. BDJ. 128(1). 15–18. 29 indexed citations

19.

Aellig, W. H., B. N. C. Prichard, & B. Scales. (1970). Blood levels of practolol following intravenous administration.. PubMed. 40(3). 573P–573P. 9 indexed citations

20.

Aellig, W. H., et al.. (1970). Vasovagal faint in the supine position.. BMJ. 4(5731). 348–348. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact